NOVOZYMES A/S
Last · CopenhagenDKK 458.00+9.00 (+2.00%)live · yahoo · 4h ago
Vol 1.01M ≈ 464.78M
MA10MA20MA50
Market cap——
P/E · TTM44.8fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume1.0Msession
Issuer
Legal nameNOVOZYMES A/S
HQEurope (EU)
ListingEU 529900T6WNZXD2R3JW38
SectorMaterials
CurrencyEUR
Entity registrylei:529900T6WNZXD2R3JW38
Websitewww.novonesis.com
| Revenue | €2.2B |
|---|---|
| Operating income | €519.6M |
| Net income | €370.8M |
| Free cash flow | €345.7M |
| Operating margin | 23.2% |
| Net margin | 16.6% |
| Return on equity | 3.3% |
| Period | 2026 |
Loading chart…
OpenFilings analyst
Our analyst
ANNUAL · 2026-04-07
From latest ANNUAL · 2026-04-07
- Current Ratio Low
Red flags
- Current Ratio Low — Current ratio 0.72
Earnings transcripts
Documents
FormReporting forFiledFlags
Showing 5 of 183 filings